SLC24A3 and neoplasm: The results demonstrated that downregulation of SLC24A3 in tumor tissues was greatly associated with better overall survival (log rank p = 0.0019; Figure 2(d)), disease-free survival (log rank p = 0.049; Figure 2(e)), and progression-free survival (log rank p = 0.049; Figure 2(f)) among patients with CESC.